Jov88, LC has definitely layered down the markers . If IMU hits...

First 13415 Last

Share
Profile

Follow
Taureanbull

3,141 Posts.

6693

04/05/24

07:24

Post #: 73661460
Share

Originally posted by Jov88 ↑

Agree, great presentation from Leslie.

I did cringe a little though to the “I don’t know” response to why the companies share price isn’t performing.

It was great to hear some commercial values and comments thrown around. As you referenced @Taureanbull Gilead bought Kite for $11bil a few years back, basically for a couple CAR-T therapys. Those CAR-Ts aren’t performing that well, Kite had large layoffs also last year, mayjor contributing factor is US treatments centres to support CAR-T manufacturing are lacking, even if the demand is there, they just aren’t able to produce CAR-T therapies in an efficient effective way to really ramp up their revenue.

If Azer cel kicks some goals in it’s 1b and moves to registrational it’ll defs be a big taking point in big pharma boardrooms.

That should be around the same time we have initial combo data or at least confirmed CD19 tagging on solid tumours…not to mention MAST high cohort data.

It’s anyone’s guess when the big money will let this thing run again though…

Expand

Jov88, LC has definitely layered down the markers . If IMU hits them which looks a certainty from my perspective. It’ll be US Investors asking why it’s not $80.

It’s easy to see why the SP is .08. The other day there was 360,000 on the BUY with 79 orders. We’ve got hundreds of little Slicks lurking here. And they wet there pants with excitement they make .003 on 5000 shares.

Last edited by Taureanbull: 04/05/24

IMU Price at posting: 8.2¢ Sentiment: Buy Disclosure: Held
24 Upvote

1 Great analysis

Reply